AU737710B2 - Antimicrobial peptide - Google Patents

Antimicrobial peptide Download PDF

Info

Publication number
AU737710B2
AU737710B2 AU73858/98A AU7385898A AU737710B2 AU 737710 B2 AU737710 B2 AU 737710B2 AU 73858/98 A AU73858/98 A AU 73858/98A AU 7385898 A AU7385898 A AU 7385898A AU 737710 B2 AU737710 B2 AU 737710B2
Authority
AU
Australia
Prior art keywords
isolated
isolated polynucleotide
protein
polynucleotide
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU73858/98A
Other languages
English (en)
Other versions
AU7385898A (en
Inventor
Henrik S. Olsen
Steven M. Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU7385898A publication Critical patent/AU7385898A/en
Application granted granted Critical
Publication of AU737710B2 publication Critical patent/AU737710B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU73858/98A 1997-05-14 1998-05-14 Antimicrobial peptide Ceased AU737710B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4641597P 1997-05-14 1997-05-14
US60/046415 1997-05-14
PCT/US1998/009796 WO1998051794A1 (en) 1997-05-14 1998-05-14 Antimicrobial peptide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU59888/01A Division AU5988801A (en) 1997-05-14 2001-08-15 Antimicrobial peptide

Publications (2)

Publication Number Publication Date
AU7385898A AU7385898A (en) 1998-12-08
AU737710B2 true AU737710B2 (en) 2001-08-30

Family

ID=21943326

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73858/98A Ceased AU737710B2 (en) 1997-05-14 1998-05-14 Antimicrobial peptide

Country Status (8)

Country Link
US (3) US6143498A (https=)
EP (1) EP0980431A1 (https=)
JP (1) JP2001527412A (https=)
KR (1) KR20010012554A (https=)
CN (1) CN1260834A (https=)
AU (1) AU737710B2 (https=)
CA (1) CA2290781A1 (https=)
WO (1) WO1998051794A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984622B2 (en) * 1998-03-25 2006-01-10 The Regents Of The University Of California Use of lipopolysaccharides to manage corneal infections and wounds
WO2001023002A1 (en) * 1999-09-30 2001-04-05 National Jewish Medical And Research Center Method for inhibition of pathogenic microorganisms
ATE319740T1 (de) * 2000-06-08 2006-03-15 Ipf Pharmaceuticals Gmbh Verfahren zur gewinnung und anwendung von antibiotisch wirksamen peptiden zur behandlung von infektionskrankheiten
US6846804B2 (en) * 2000-06-29 2005-01-25 University Of Maryland, College Park Office Of Technology Commercialization Construction of a structural variant of sublancin to facilitate its isolation and use in bioremediation of environmental contamination by gram-positive spore formers such as bacillus anthrasis
DE10129983A1 (de) * 2001-06-13 2003-01-30 Univ Eberhard Karls Antimikrobiell wirkendes Peptid
US8329865B2 (en) * 2001-06-13 2012-12-11 Eberhard-Karls-Univresitaet Tuebingen Universitaetsklinikum Antimicrobially active peptides
US7507787B2 (en) * 2001-12-03 2009-03-24 The University Of British Columbia Effectors of innate immunity
AU2003215257A1 (en) * 2002-02-19 2003-09-09 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Modified defensins and their use
DE60335101D1 (de) 2002-04-25 2011-01-05 Toagosei Co Ltd Antimikrobielles polypeptid und nutzung davon
US7033769B2 (en) * 2002-05-23 2006-04-25 The United States Of America As Represented By The Secretary Of The Army Method for discovering one or more peptides adapted for specific binding to a microorganism of interest
JP4524671B2 (ja) 2003-10-29 2010-08-18 東亞合成株式会社 抗菌ペプチド及びその利用
JP4507080B2 (ja) 2004-07-30 2010-07-21 東亞合成株式会社 抗菌ペプチド及びその利用
JP4730584B2 (ja) 2004-12-06 2011-07-20 東亞合成株式会社 抗菌ペプチド及びその利用
US7485619B2 (en) * 2005-01-31 2009-02-03 Yeon Sook KIM Antimicrobial agent
WO2006088010A1 (ja) 2005-02-15 2006-08-24 Toagosei Co., Ltd. 抗菌ペプチド及びその利用
US20070231833A1 (en) * 2005-05-23 2007-10-04 Arcidiacono Steven M Labeled antimicrobial peptides and method of using the same to detect microorganisms of interest
JP2009535027A (ja) * 2006-04-27 2009-10-01 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 抗菌ペプチド
US20100150985A1 (en) * 2008-04-24 2010-06-17 George Just Dental Implant, Endodontic Instrument, and Dental Filling Material Coated with a Peptide-Based Antimicrobial and Methods of Using and Making the Same
FR2944019B1 (fr) * 2009-04-03 2011-04-22 Biomerieux Sa Procede de dosage de la prodefensine-a6 pour le diagnostic in vitro du cancer colorectal.
WO2011137368A2 (en) 2010-04-30 2011-11-03 Life Technologies Corporation Systems and methods for analyzing nucleic acid sequences
US9268903B2 (en) 2010-07-06 2016-02-23 Life Technologies Corporation Systems and methods for sequence data alignment quality assessment
KR101303299B1 (ko) * 2010-10-08 2013-09-03 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 항균 펩타이드의 피부 세포 재생 촉진제로서의 신규한 용도
CN103533947A (zh) 2010-12-28 2014-01-22 卡梅迪斯有限公司 用于治疗和预防感染的植物提取物
US10967031B2 (en) 2010-12-28 2021-04-06 Kamedis Ltd. Synergistic herbal compositions with prebiotic properties for treatment of skin infections, allergies and inflammation
EP3385277A1 (en) 2013-03-15 2018-10-10 F. Hoffmann-La Roche AG Il-22 polypeptides and il-22 fc fusion proteins and methods of use
US11612225B2 (en) * 2018-05-03 2023-03-28 Nicholas Schwartz Securing beach net
CN115428088A (zh) 2020-02-13 2022-12-02 10X基因组学有限公司 用于基因表达和dna染色质可及性的联合交互式可视化的系统和方法
EP4121087A4 (en) 2020-03-18 2024-04-03 The University of Hong Kong ANTI-VIRAL PEPTIDE COMPOSITIONS AND METHODS OF USE
EP4457237A4 (en) * 2021-12-27 2025-11-12 Versitech Ltd ANTIVIRAL PEPTIDES AND THEIR METHODS OF USE
CN116496916A (zh) * 2022-12-27 2023-07-28 安徽斯拜科生物科技有限公司 一种高产hbd-2的毕赤酵母工程菌株及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026106A1 (en) * 1993-05-11 1994-11-24 The Children's Hospital Of Philadelphia Novel tracheal antimicrobial peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU670108B2 (en) * 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
US5470955A (en) * 1993-02-02 1995-11-28 Dartmouth College Antibodies which specifically bind mcl-1 polypeptide
DE4427531A1 (de) * 1994-08-04 1996-02-08 Forssmann Wolf Georg Humanes zirkulierendes beta-Defensin hBD-1
WO1997022624A2 (de) * 1995-12-16 1997-06-26 Beiersdorf Ag Gegen bakterien, mycota und viren wirksame vertebratenproteine und dessen kosmetische zubereitungen
DE19629119A1 (de) * 1995-12-16 1997-06-19 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame kosmetische Zubereitungen enthaltend Vertebratenproteine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026106A1 (en) * 1993-05-11 1994-11-24 The Children's Hospital Of Philadelphia Novel tracheal antimicrobial peptides

Also Published As

Publication number Publication date
US6420116B1 (en) 2002-07-16
CA2290781A1 (en) 1998-11-19
JP2001527412A (ja) 2001-12-25
US20050004355A1 (en) 2005-01-06
AU7385898A (en) 1998-12-08
US6143498A (en) 2000-11-07
CN1260834A (zh) 2000-07-19
EP0980431A1 (en) 2000-02-23
KR20010012554A (ko) 2001-02-15
US7223840B2 (en) 2007-05-29
WO1998051794A1 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
AU737710B2 (en) Antimicrobial peptide
US6479254B2 (en) Apoptosis inducing molecule II
EP1015582A1 (en) Breast cancer specific gene 1
US6303338B1 (en) Pancreas-derived plasminogen activator inhibitor
US6419917B1 (en) Human chemotactic protein
WO1998015624A1 (en) Galectin 8, 9, 10 and 10sv
US20040014668A1 (en) Human NK3-related prostate specific gene 1
US20030166898A1 (en) Myelin oligodendrocyte glycoprotein-like protein (MOGp)
WO1998033912A9 (en) MYELIN OLIGODENDROCYTE GLYCOPROTEIN-LIKE PROTEIN (MOGp) AND METHODS OF USE
US6495520B2 (en) Apoptosis Inducing Molecule II and methods of use
US20020110867A1 (en) Cardiac and pancreatic protein and gene
NZ513514A (en) Antimicrobial peptide
NZ500864A (en) Isolated nucleic acid molecules encoding human defensin peptide
WO1998044112A9 (en) Human muscle derived growth factor - cardiac and pancreatic protein (capp) and gene
AU5988801A (en) Antimicrobial peptide
MXPA99010235A (en) Antimicrobial peptide
US6379923B1 (en) ELL2, a new member of an ELL family of RNA polymerase II elongation factors
WO1998044111A1 (en) Thymus receptor tyrosine kinase (trtk) and methods of use
US7109306B2 (en) Antibodies to human oncogene induced secreted protein I
AU734384B2 (en) Apoptosis inducing molecule II
WO1999009161A1 (en) Pancreas-derived plasminogen activator inhibitor
AU2004202460A1 (en) Apoptosis Inducing Molecule II

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)